You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: March 23, 2025

Details for Patent: 11,000,522


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 11,000,522
Title:Bromocriptine formulations
Abstract: The present application describes pharmaceutical formulations of bromocriptine mesylate and methods of manufacturing and using such formulations. The formulations are useful for improving glycemic control in the treatment of type 2 diabetes.
Inventor(s): Cincotta; Anthony H. (Tiverton, RI), Bowe; Craig Michael (Encinitas, CA), Stearns; Paul Clark (San Diego, CA), Weston; Laura Jean (Escondido, CA)
Assignee: VeroScience LLC (Tiverton, RI)
Application Number:16/878,451
Patent Claim Types:
see list of patent claims
Use; Composition; Formulation; Compound; Dosage form;
Patent landscape, scope, and claims:

Understanding the Scope and Claims of U.S. Patents: A Deep Dive into the Patent Landscape

Introduction to U.S. Patents

The United States Patent and Trademark Office (USPTO) has been a cornerstone of American innovation, granting patents that protect and promote inventive ideas. The recent issuance of U.S. patent number 11,000,000 marks a significant milestone in this journey, highlighting the ongoing importance of patents in driving technological advancement and economic growth.

Historical Context of U.S. Patents

Patents in the United States have a rich history, dating back to the early days of the nation. Before the Patent Act of 1836, patents were unnumbered and identified only by the name of the patentee and the date of issue, known as "X-patents." The first numbered patent, Patent No. 1, was granted to Senator John Ruggles on July 11, 1836, for a traction wheel for steam locomotives[1].

The Significance of Patent 11,000,000

The issuance of U.S. patent number 11,000,000 is a testament to the enduring tradition of American innovation. This patent, granted to co-inventors Saravana B. Kumar and Jason S. Diedering of 4C Medical Technologies, Inc., is for a utility patent that provides a new method for delivering, positioning, and/or repositioning a collapsible and expandable stent frame within a patient’s heart chamber. This milestone underscores the continuous effort and ingenuity of American inventors in solving complex problems and improving lives[1].

Understanding Patent Claims

Patent claims are the heart of any patent application, defining the scope of protection for an invention. The strategic management of claims is crucial for maximizing the value of a patent.

Claim Structure and Management

In the United States, the initial patent application filing fee covers up to 3 independent claims and a total of 20 claims. However, it is a common misconception that the quantity of claims directly correlates with the strength or value of the patent. Instead, the strategic composition and management of these claims are key. Consolidating multiple dependent claims into fewer, broader independent claims can facilitate application approval and enhance the patent’s effectiveness[2].

Independent Claim Length and Count

Research has shown that two simple metrics—independent claim length and independent claim count—can be used to measure patent scope. Narrower claims at publication are associated with a higher probability of grant and a shorter examination process. This highlights the importance of crafting claims that are clear, concise, and well-defined[3].

Maximizing Patent Value Through Claim Management

Effective claim management is not just about numerical optimization but also about ensuring that each patent utilizes its full entitlement of claims. Here are some strategies to maximize patent value:

Utilizing the Full Quota of Claims

Adding a new dependent claim for every claim that is canceled ensures that the final patent uses the full quota of claims allowed by the filing fee. This practice enhances the patent’s breadth and flexibility without incurring additional costs[2].

Defensive Capabilities and Commercial Value

Each claim in a patent application can be viewed as a unique tool for protecting different facets of the invention. By ensuring that each patent utilizes its full complement of claims, inventors can secure more robust and nuanced protection. This enhances the patent’s defensive capabilities and its value in potential licensing discussions or infringement disputes[2].

Patent Litigation and Valuation

The value of a patent is also influenced by its potential in litigation and valuation.

Post-Reform Landscape

The America Invents Act (AIA) of 2011 introduced significant changes to patent law, including the switch from a first-to-invent to a first-to-file rule and new processes for challenging patents. These reforms have impacted patent litigation and valuation, emphasizing the need for accurate assessments of income, market effects, and costs associated with the use of a particular piece of intellectual property[4].

Accurate Valuation

Accurate valuation of patents involves detailed assessments of various factors, including income, market effects, and associated costs. This comprehensive approach helps in determining the true value of a patent and its potential in commercial and legal contexts[4].

The Need for a Small Claims Patent Court

The complexity and costs associated with patent litigation have led to discussions about the need for a small claims patent court.

Feasibility and Structure

The Administrative Conference of the United States (ACUS) has conducted studies on the feasibility and potential structure of a small claims patent court. This initiative aims to address the legal, policy, and practical considerations involved in establishing such a court, which could provide a more accessible and cost-effective avenue for resolving patent disputes[5].

Industry Expert Insights

Industry experts and legal practitioners play a crucial role in shaping the patent landscape.

Consultative Group Contributions

ACUS's consultative group, comprising academic experts and legal practitioners, has provided valuable insights into the methodology and implications of a small claims patent court. Their contributions highlight the importance of stakeholder input in shaping patent policy and practice[5].

Examples and Statistics

  • Patent Milestones: The issuance of U.S. patent number 11,000,000 is just three years after the issuance of patent number 10,000,000, demonstrating the rapid pace of innovation[1].
  • Claim Optimization: Studies have shown that patents with narrower claims at publication have a higher probability of grant and a shorter examination process, emphasizing the importance of claim management[3].

Key Takeaways

  • Historical Significance: U.S. patents have a rich history, with significant milestones like the issuance of patent number 11,000,000 highlighting American innovation.
  • Claim Management: Strategic management of claims is crucial for maximizing patent value and ensuring robust protection.
  • Litigation and Valuation: Accurate valuation and the post-reform landscape under the AIA are critical in understanding the commercial and legal value of patents.
  • Small Claims Court: The potential for a small claims patent court could provide a more accessible and cost-effective avenue for resolving patent disputes.

FAQs

Q: What is the significance of U.S. patent number 11,000,000? A: U.S. patent number 11,000,000 marks a significant milestone in American innovation, recognizing the continuous effort and ingenuity of American inventors.

Q: How does the structure of patent claims impact the value of a patent? A: The strategic composition and management of patent claims can significantly enhance a patent’s effectiveness and value by ensuring robust protection and maximizing the use of allowed claims.

Q: What changes did the America Invents Act introduce to patent law? A: The AIA introduced a switch from a first-to-invent to a first-to-file rule, new processes for challenging patents, and other reforms that have impacted patent litigation and valuation.

Q: Why is there a discussion about a small claims patent court? A: The discussion is driven by the need for a more accessible and cost-effective avenue for resolving patent disputes, addressing the complexity and costs associated with current patent litigation processes.

Q: How do independent claim length and count affect patent scope? A: Narrower claims at publication are associated with a higher probability of grant and a shorter examination process, highlighting the importance of crafting clear and well-defined claims.

Sources

  1. United States Issues Patent Number 11,000,000 - Kim and Lahey.
  2. Maximizing Patent Value: A Strategic Approach to Claim Management - Harrity LLP.
  3. Patent Claims and Patent Scope - SSRN.
  4. A Look at Patent Litigation and Valuation Post Reform - Analysis Group.
  5. U.S. Patent Small Claims Court - Administrative Conference of the United States.

More… ↓

⤷  Try for Free


Drugs Protected by US Patent 11,000,522

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Veroscience CYCLOSET bromocriptine mesylate TABLET;ORAL 020866-001 May 5, 2009 RX Yes Yes ⤷  Try for Free ⤷  Try for Free ADJUNCT TO DIET AND EXERCISE TO IMPROVE GLYCEMIC CONTROL IN ADULTS WITH TYPE 2 DIABETIS BY ORALLY ADMINISTERING A DOSAGE FORM COMPRISING BROMOCRIPTINE AND ONE OR MORE EXCIPIENTS AS RECITED IN CLAIMS 1 AND 11 ⤷  Try for Free
Veroscience CYCLOSET bromocriptine mesylate TABLET;ORAL 020866-001 May 5, 2009 RX Yes Yes ⤷  Try for Free ⤷  Try for Free ADJUNCT TO DIET AND EXERCISE TO IMPROVE GLYCEMIC CONTROL IN ADULTS WITH TYPE 2 DIABETIS BY ORALLY ADMINISTERING A DOSAGE FORM COMPRISING BROMOCRIPTINE AND ONE OR MORE EXCIPIENTS AS RECITED IN CLAIMS 13 AND 23 ⤷  Try for Free
Veroscience CYCLOSET bromocriptine mesylate TABLET;ORAL 020866-001 May 5, 2009 RX Yes Yes ⤷  Try for Free ⤷  Try for Free ADJUNCT TO DIET AND EXERCISE TO IMPROVE GLYCEMIC CONTROL IN ADULTS WITH TYPE 2 DIABETIS BY ORALLY ADMINISTERING A DOSAGE FORM COMPRISING BROMOCRIPTINE AND ONE OR MORE EXCIPIENTS AS RECITED IN CLAIMS 1, 11, AND 12 ⤷  Try for Free
Veroscience CYCLOSET bromocriptine mesylate TABLET;ORAL 020866-001 May 5, 2009 RX Yes Yes ⤷  Try for Free ⤷  Try for Free ADJUNCT TO DIET EXERCISE TO IMPROVE GLYCEMIC CONTROL IN ADULTS WITH TYPE 2 DIABETIS BY ORALLY ADMINISTERING A DOSAGE FORM COMPRISING BROMOCRIPTINE AND ONE OR MORE EXCIPIENTS AS RECITED IN CLAIMS 13, 23, AND 24 ⤷  Try for Free
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 11,000,522

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Argentina 091351 ⤷  Try for Free
Australia 2013256558 ⤷  Try for Free
Australia 2016202572 ⤷  Try for Free
Australia 2018203021 ⤷  Try for Free
Brazil 112014027087 ⤷  Try for Free
Canada 2872300 ⤷  Try for Free
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.